BRIEF-Nuvation Bio To Acquire Anheart Therapeutics In All-Stock Transaction-February 2024-www.financetom.com

BRIEF-Nuvation Bio To Acquire Anheart Therapeutics In All-Stock Transaction

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Nuvation Bio To Acquire Anheart Therapeutics In All-Stock Transaction

Mar 25, 2024 6:51 AM

March 25 (Reuters) - Nuvation Bio Inc ( NUVB ):

* NUVATION BIO TO ACQUIRE ANHEART THERAPEUTICS IN ALL-STOCK

TRANSACTION

* NUVATION BIO INC ( NUVB ) - NUVATION BIO WILL CONTINUE TO BE LED BY

ITS

CURRENT MANAGEMENT TEAM

* NUVATION BIO INC ( NUVB ) - FOLLOWING DEAL, MIN CUI AND JUNYUAN

JERRY

WANG WILL JOIN NUVATION BIO BOARD OF DIRECTORS

* NUVATION BIO ( NUVB ) - AS ANHEART'S PARENT CO AFTER ACQUISITION,

NUVATION BIO WILL OWN ALL OF ANHEART'S ASSETS, INCLUDING

ANHEART'S INTELLECTUAL PROPERTY

* NUVATION-FORMER SHAREHOLDERS OF ANHEART WILL OWN ABOUT 33%

AND

CURRENT STOCKHOLDERS OF CO WILL OWN ABOUT 67% OF NUVATION BIO ON

FULLY DILUTED BASIS

* NUVATION BIO INC ( NUVB ) - ACQUISITION IS EXPECTED TO CLOSE IN Q2

2024

Source text for Eikon:

Further company coverage:

Previous page： Liquidia Seeks Stay on FDA Exclusivity Approval of Rival Version of Hypertension Drug Next page： Allbirds to Launch 1-For-20 Reverse Stock Split

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Liquidia Seeks Stay on FDA Exclusivity Approval of Rival Version of Hypertension Drug

Sep 1, 2024

05:42 PM EDT, 08/28/2024 (MT Newswires) -- Liquidia ( LQDA ) is seeking a preliminary injunction on an Aug. 16 decision by the US Food and Drug Administration to keep its Yutrepia drug off the market until the exclusivity period for a rival medication expires May next year, according to court documents filed Tuesday. Liquidia ( LQDA ) sued the...

Allbirds to Launch 1-For-20 Reverse Stock Split

Sep 1, 2024

09:25 AM EDT, 08/30/2024 (MT Newswires) -- Allbirds ( BIRD ) said Friday it will launch a 1-for-20 reverse stock split of its class A shares and class B shares following approval by its board. The ratio is inside the range approved by shareholders at a meeting on Aug. 13, Allbirds ( BIRD ) said. The split was designed to...

Salesforce Q2 Non-GAAP EPS, Revenue Increase; Issues Outlook

Sep 1, 2024

04:43 PM EDT, 08/28/2024 (MT Newswires) -- Salesforce ( CRM ) reported Q2 non-GAAP earnings Wednesday of $2.56 per diluted share, up from $2.12 a year earlier. Analysts polled by Capital IQ expected $2.36. Revenue for the quarter ended July 31 was $9.33 billion, up from $8.60 billion a year earlier. Analysts surveyed by Capital IQ expected $9.23 billion. The...

TC Energy's South Bow Closes $5.86 Billion Notes Offering Ahead of Spinoff

Sep 1, 2024

05:42 PM EDT, 08/28/2024 (MT Newswires) -- TC Energy ( TRP ) said Wednesday that South Bow closed about CA$7.9 billion ($5.86 billion) notes offering linked to the spinoff of TC Energy's ( TRP ) liquids pipelines business. The offering consists of $700 million of 4.911% senior unsecured notes due 2027, $1 billion 5.026% senior unsecured notes due 2029, $1.25...